Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Licensing Discipline topic

No spam. Unsubscribe anytime.

Commission accepts $7,500 settlement and 12-month probation for pharmacist after inspection found multiple violations

5353591 · July 8, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Connecticut Pharmacy Commission accepted a settlement placing a respondent pharmacist’s license on 12 months’ probation and imposing a $7,500 payment after inspectors identified numerous record‑keeping, staffing and controlled‑substance deficiencies.

The Connecticut Pharmacy Commission accepted a settlement Tuesday that places a pharmacist’s license on probation for 12 consecutive months and requires a $7,500 voluntary monetary payment following a routine drug‑control inspection.

The settlement stems from case number 2024‑3107, in which department attorneys said inspectors identified multiple violations, including failures to maintain sanitary premises, to register and document pharmacy technicians properly, and to reconcile and report controlled‑substance inventory losses. "The agreement that we landed on that we felt was fair was a monetary payment in the amount of $7,500 as well as the issuance of a letter of reference by the Commissioner of Consumer Protection," said Katrina Parker, a staff attorney with the Consumer Protection Department. "Should this agreement be accepted by the Commission, [there would be] immediate placement of the respondent's pharmacy license into a probationary status for a period of 12 consecutive months."

Parker told commissioners the inspection identified 17 separate alleged violations tied to premises condition, technician registration and training, missing or inaccurate perpetual inventory records for controlled substances, and failures to timely report losses to the Commissioner of Consumer Protection. Parker also said the department agreed to remove one count after the respondent produced evidence that an earlier training attendance issue stemmed from confusion about a remote training format during the pandemic.

Commissioners discussed the history of the matter and noted the case’s length; Parker said some issues dated back nearly two years and had overlapped with a prior sale of the pharmacy. She told the panel the department had conducted follow‑up inspections and that at least one later inspection found no new issues.

A motion to accept the settlement was made and seconded; the Commission voted to approve the agreement. The record reflects at least one recusal or abstention during the vote. The settlement includes monitoring and a warning that future or repeat violations could lead to stricter discipline, up to suspension of the license.

Background: Department staff said the alleged failures included not maintaining a current pharmacist certificate available for inspection, not registering technicians within 30 days of their training start, not documenting initial technician training with signatures, not reconciling monthly perpetual inventories for controlled substances, and not reporting controlled‑substance losses within the regulatory 72‑hour window. The department’s description also cited incomplete quality‑assurance review records and missing documentation related to insulin and other diabetes devices.

The settlement will be executed and monitored by the Consumer Protection Department; the respondent will remain under the department’s scrutiny during the probationary period.